Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Sold by Xponance Inc.

Xponance Inc. reduced its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 3.4% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 12,674 shares of the company’s stock after selling 448 shares during the quarter. Xponance Inc.’s holdings in Ryan Specialty were worth $545,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in the company. PNC Financial Services Group Inc. grew its stake in shares of Ryan Specialty by 192.0% during the 3rd quarter. PNC Financial Services Group Inc. now owns 549 shares of the company’s stock worth $27,000 after purchasing an additional 361 shares during the period. Operose Advisors LLC purchased a new position in shares of Ryan Specialty during the third quarter valued at approximately $92,000. First Horizon Advisors Inc. lifted its stake in shares of Ryan Specialty by 27.6% during the 3rd quarter. First Horizon Advisors Inc. now owns 2,409 shares of the company’s stock worth $117,000 after purchasing an additional 521 shares during the period. UMB Bank n.a. acquired a new stake in Ryan Specialty in the 3rd quarter worth about $133,000. Finally, CHICAGO TRUST Co NA acquired a new stake in shares of Ryan Specialty in the third quarter worth approximately $212,000. 84.82% of the stock is currently owned by institutional investors and hedge funds.

Ryan Specialty Trading Down 1.8 %

RYAN stock opened at $48.94 on Friday. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 1.98. The firm has a market cap of $12.74 billion, a P/E ratio of 95.96 and a beta of 0.52. Ryan Specialty Holdings, Inc. has a 1-year low of $39.44 and a 1-year high of $56.51. The business’s 50 day moving average is $52.09 and its 200-day moving average is $46.96.

Ryan Specialty (NYSE:RYAN) last posted its earnings results on Tuesday, February 27th. The company reported $0.35 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.35. The company had revenue of $532.90 million during the quarter, compared to analysts’ expectations of $524.08 million. Ryan Specialty had a net margin of 9.36% and a return on equity of 44.84%. Ryan Specialty’s quarterly revenue was up 22.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.27 earnings per share. Equities analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.77 earnings per share for the current fiscal year.

Ryan Specialty Dividend Announcement

The company also recently declared a None dividend, which was paid on Wednesday, March 27th. Stockholders of record on Wednesday, March 13th were paid a dividend of $0.34 per share. The ex-dividend date of this dividend was Tuesday, March 12th. Ryan Specialty’s dividend payout ratio (DPR) is presently 86.28%.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on RYAN. Keefe, Bruyette & Woods upped their price target on shares of Ryan Specialty from $56.00 to $62.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 10th. JMP Securities reiterated a “market perform” rating on shares of Ryan Specialty in a research report on Monday, April 15th. Wells Fargo & Company boosted their target price on Ryan Specialty from $57.00 to $58.00 and gave the stock an “overweight” rating in a report on Thursday, April 11th. JPMorgan Chase & Co. raised their price objective on Ryan Specialty from $47.00 to $49.00 and gave the stock an “underweight” rating in a research note on Monday, April 8th. Finally, Citigroup upped their target price on Ryan Specialty from $49.00 to $52.00 and gave the company a “neutral” rating in a report on Wednesday, February 28th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $54.25.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.